These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 24635859)

  • 1. Mesenchymal stem cells with overexpression of midkine enhance cell survival and attenuate cardiac dysfunction in a rat model of myocardial infarction.
    Zhao SL; Zhang YJ; Li MH; Zhang XL; Chen SL
    Stem Cell Res Ther; 2014 Mar; 5(2):37. PubMed ID: 24635859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-assembling peptide modified with QHREDGS as a novel delivery system for mesenchymal stem cell transplantation after myocardial infarction.
    Cai H; Wu FY; Wang QL; Xu P; Mou FF; Shao SJ; Luo ZR; Zhu J; Xuan SS; Lu R; Guo HD
    FASEB J; 2019 Jul; 33(7):8306-8320. PubMed ID: 30970221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial transfection of hypoxia-inducible factor-1α and co-transplantation of mesenchymal stem cells enhance cardiac repair in rats with experimental myocardial infarction.
    Huang B; Qian J; Ma J; Huang Z; Shen Y; Chen X; Sun A; Ge J; Chen H
    Stem Cell Res Ther; 2014 Feb; 5(1):22. PubMed ID: 24507665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal stem cells over-expressing SDF-1 promote angiogenesis and improve heart function in experimental myocardial infarction in rats.
    Tang J; Wang J; Yang J; Kong X; Zheng F; Guo L; Zhang L; Huang Y
    Eur J Cardiothorac Surg; 2009 Oct; 36(4):644-50. PubMed ID: 19524448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretreatment of mesenchymal stem cells with angiotensin II enhances paracrine effects, angiogenesis, gap junction formation and therapeutic efficacy for myocardial infarction.
    Liu C; Fan Y; Zhou L; Zhu HY; Song YC; Hu L; Wang Y; Li QP
    Int J Cardiol; 2015 Jun; 188():22-32. PubMed ID: 25880576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AKT-modified autologous intracoronary mesenchymal stem cells prevent remodeling and repair in swine infarcted myocardium.
    Yu YS; Shen ZY; Ye WX; Huang HY; Hua F; Chen YH; Chen K; Lao WJ; Tao L
    Chin Med J (Engl); 2010 Jul; 123(13):1702-8. PubMed ID: 20819633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome Proliferator-Activated Receptor Gamma Promotes Mesenchymal Stem Cells to Express Connexin43 via the Inhibition of TGF-β1/Smads Signaling in a Rat Model of Myocardial Infarction.
    Hou J; Wang L; Hou J; Guo T; Xing Y; Zheng S; Zhou C; Huang H; Long H; Zhong T; Wu Q; Wang J; Wang T
    Stem Cell Rev Rep; 2015 Dec; 11(6):885-99. PubMed ID: 26275398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial injection with GSK-3β-overexpressing bone marrow-derived mesenchymal stem cells attenuates cardiac dysfunction after myocardial infarction.
    Cho J; Zhai P; Maejima Y; Sadoshima J
    Circ Res; 2011 Feb; 108(4):478-89. PubMed ID: 21233455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transplantation of mesenchymal stem cells preconditioned with hydrogen sulfide enhances repair of myocardial infarction in rats.
    Xie X; Sun A; Zhu W; Huang Z; Hu X; Jia J; Zou Y; Ge J
    Tohoku J Exp Med; 2012 Jan; 226(1):29-36. PubMed ID: 22186034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stem cells modified with stromal cell-derived factor 1 alpha improve cardiac remodeling via paracrine activation of hepatocyte growth factor in a rat model of myocardial infarction.
    Tang J; Wang J; Guo L; Kong X; Yang J; Zheng F; Zhang L; Huang Y
    Mol Cells; 2010 Jan; 29(1):9-19. PubMed ID: 20016947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C1q/tumor necrosis factor-related protein-3-engineered mesenchymal stromal cells attenuate cardiac impairment in mice with myocardial infarction.
    Zhang Z; Zhu L; Feng P; Tan Y; Zhang B; Gao E; Wang X; Fan C; Wang X; Yi W; Sun Y
    Cell Death Dis; 2019 Jul; 10(7):530. PubMed ID: 31296837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of chemokine and angiogenic factor genes and mesenchymal stem cells could enhance angiogenesis and improve cardiac function after acute myocardial infarction in rats.
    Tang J; Wang J; Zheng F; Kong X; Guo L; Yang J; Zhang L; Huang Y
    Mol Cell Biochem; 2010 Jun; 339(1-2):107-18. PubMed ID: 20058054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of Atorvastatin combined with adipose-derived mesenchymal stem cell transplantation on cardiac function in rats with acute myocardial infarction.
    Cai A; Zheng D; Dong Y; Qiu R; Huang Y; Song Y; Jiang Z; Rao S; Liao X; Kuang J; Dai G; Mai W
    Acta Biochim Biophys Sin (Shanghai); 2011 Nov; 43(11):857-66. PubMed ID: 21983658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal stem cells enhanced cardiac nerve sprouting via nerve growth factor in a rat model of myocardial infarction.
    Chen J; Zheng S; Huang H; Huang S; Zhou C; Hou J; Jiang J; Wang J; Wu W; Wang T
    Curr Pharm Des; 2014; 20(12):2023-9. PubMed ID: 23844741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of transplantation with bone marrow-derived mesenchymal stem cells modified by Survivin on experimental stroke in rats.
    Liu N; Zhang Y; Fan L; Yuan M; Du H; Cheng R; Liu D; Lin F
    J Transl Med; 2011 Jul; 9():105. PubMed ID: 21733181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Over-expression of CXCR4 on mesenchymal stem cells augments myoangiogenesis in the infarcted myocardium.
    Zhang D; Fan GC; Zhou X; Zhao T; Pasha Z; Xu M; Zhu Y; Ashraf M; Wang Y
    J Mol Cell Cardiol; 2008 Feb; 44(2):281-92. PubMed ID: 18201717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The enhanced effect and underlying mechanisms of mesenchymal stem cells with IL-33 overexpression on myocardial infarction.
    Chen Y; Zuo J; Chen W; Yang Z; Zhang Y; Hua F; Shao L; Li J; Chen Y; Yu Y; Shen Z
    Stem Cell Res Ther; 2019 Sep; 10(1):295. PubMed ID: 31547872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guanxin Danshen Formulation improved the effect of mesenchymal stem cells transplantation for the treatment of myocardial infarction probably via enhancing the engraftment.
    Han XJ; Li H; Liu CB; Luo ZR; Wang QL; Mou FF; Guo HD
    Life Sci; 2019 Sep; 233():116740. PubMed ID: 31398416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chitosan/silk fibroin modified nanofibrous patches with mesenchymal stem cells prevent heart remodeling post-myocardial infarction in rats.
    Chen J; Zhan Y; Wang Y; Han D; Tao B; Luo Z; Ma S; Wang Q; Li X; Fan L; Li C; Deng H; Cao F
    Acta Biomater; 2018 Oct; 80():154-168. PubMed ID: 30218777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunomodulation by systemic administration of human-induced pluripotent stem cell-derived mesenchymal stromal cells to enhance the therapeutic efficacy of cell-based therapy for treatment of myocardial infarction.
    Sun SJ; Lai WH; Jiang Y; Zhen Z; Wei R; Lian Q; Liao SY; Tse HF
    Theranostics; 2021; 11(4):1641-1654. PubMed ID: 33408772
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.